Vilazodone Film-Coated Tablets

Form: Film-Coated Tablets

Strength: 10 mg, 20 mg, 40 mg

Reference Brands: Viibryd®(US)

Category: Antipsychotropic Drugs

Vilazodone film-coated tablets are FDA-approved in the United States for the treatment of major depressive disorder (MDD) in adults. It combines SSRI activity with 5-HT1A partial agonism, offering a unique antidepressant profile. U.S. regulatory requirements include a Boxed Warning for increased risk of suicidal thoughts in young adults, GMP-compliant manufacturing, and bioequivalence data for generics. In the European Union, vilazodone is not widely marketed but may be accessed via special import pathways or national applications. EU dossier submission would require Risk Management Plans (RMPs), clinical safety data, and pharmacovigilance commitments. For global sourcing and regulatory-ready supply, visit Pharmatradz.com.